In an animal model, Hao et al.9 demonstrated that Gal-3 inhibition ameliorated hypoxia-induced pulmonary artery hypertension and reduced the inflammatory response, and they showed the genetic and molecular pathways involved. This evidence concerns the gene LGALS3 and pulmonary arterial hypertension.